scholarly article | Q13442814 |
P356 | DOI | 10.1034/J.1399-6576.2001.045004427.X |
P698 | PubMed publication ID | 11300380 |
P2093 | author name string | Takahashi S | |
Akiyoshi K | |||
Irita K | |||
Yamaura K | |||
Taniyama T | |||
P2860 | cites work | Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside | Q28362454 |
The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation | Q28379336 | ||
Regulation of macrophage gene expression by pro- and anti-inflammatory cytokines | Q33868159 | ||
Gastrointestinal luminal PCO2 tonometry: an update on physiology, methodology and clinical applications | Q33877372 | ||
Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery | Q34293617 | ||
Prediction of requirement for, and outcome of, prolonged mechanical ventilation following cardiac surgery | Q39455149 | ||
PDE isoenzymes as targets for anti-asthma drugs | Q40432650 | ||
Associations between intramucosal acidosis in the gut and organ failure. | Q40873467 | ||
Gastric intramucosal pH. A better predictor of multiorgan dysfunction syndrome and death than oxygen-derived variables in patients with sepsis | Q41074980 | ||
Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients | Q41089036 | ||
Does gastric tonometry work? No. | Q41137846 | ||
Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. | Q41403952 | ||
The inflammatory response to cardiopulmonary bypass | Q41480038 | ||
Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies | Q41604810 | ||
The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations | Q41606619 | ||
Comparison of gastric intramucosal pH with measures of oxygen transport and consumption in critically ill patients | Q41848063 | ||
Gastric tonometry and venous oximetry in cardiac surgery patients. | Q42059012 | ||
Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States | Q44446042 | ||
Elevation of cardiac output and oxygen delivery improves outcome in septic shock | Q46090707 | ||
Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes. | Q47959852 | ||
Effects of temperature and flow rate on regional blood flow and metabolism during cardiopulmonary bypass | Q48473645 | ||
Milrinone modulates endotoxemia, systemic inflammation, and subsequent acute phase response after cardiopulmonary bypass (CPB). | Q51479777 | ||
Influence of enoximone on systemic and splanchnic oxygen utilization and endotoxin release following cardiopulmonary bypass. | Q51547412 | ||
Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production. | Q51571631 | ||
Dopexamine and dopamine in the prevention of low gastric mucosal pH following cardiopulmonary by-pass. | Q51590181 | ||
Comparison of gastric air tonometry with standard saline tonometry. | Q52893918 | ||
Systemic inflammatory response syndrome after cardiac operations. | Q53987195 | ||
Effects of vasoactive drugs on gastric intramucosal pH | Q64127276 | ||
Sodium bicarbonate administration affects the diagnostic accuracy of gastrointestinal tonometry in acute mesenteric ischemia | Q67493545 | ||
Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients | Q67599326 | ||
Effect of a novel inhibitor of cyclic AMP phosphodiesterase, E-1020, on cytosolic Ca++ level and contraction in vascular smooth muscle | Q68279356 | ||
Predictive value of the stomach wall pH for complications after cardiac operations: comparison with other monitoring | Q70320674 | ||
Effects of intracoronary infusion of an inotropic agent, E-1020 (loprinone hydrochloride), on cardiac function: evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship | Q70789366 | ||
Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations | Q70874116 | ||
Hepatic blood flow and right ventricular function during cardiac surgery assessed by transesophageal echocardiography | Q71306931 | ||
Effect of dopexamine on calculated low gastric intramucosal pH following valve replacement | Q71772962 | ||
Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery | Q72109123 | ||
Dobutamine-induced dissociation between changes in splanchnic blood flow and gastric intramucosal pH after cardiac surgery | Q72159160 | ||
Effect of cardiopulmonary bypass on gastrointestinal perfusion and function | Q72781227 | ||
Comparison of the effects on arterial-ventricular coupling between phosphodiesterase inhibitor and dobutamine in the diseases human heart | Q72842545 | ||
Postoperative inflammatory response after autologous and allogeneic blood transfusion | Q73747078 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 427-434 | |
P577 | publication date | 2001-04-01 | |
P1433 | published in | Acta Anaesthesiologica Scandinavica | Q59829 |
P1476 | title | Effects of olprinone, a new phosphodiesterase inhibitor, on gastric intramucosal acidosis and systemic inflammatory responses following hypothermic cardiopulmonary bypass | |
P478 | volume | 45 |
Q35112320 | A review of anti-inflammatory strategies in cardiac surgery |
Q41820543 | Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions |
Q37657841 | Clinical and molecular genetics of the phosphodiesterases (PDEs). |
Q35549429 | Gastric tonometry guided therapy in critical care patients: a systematic review and meta-analysis |
Q35096807 | Phosphodiesterases as therapeutic targets |
Search more.